Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro

Sonia Meconi1, Alain Vercellone, Florence Levillain

  • 1Department Molecular Mechanisms of Mycobacterial Infections, IPBS, CNRS UMR5089, Toulouse 31077, France.

Cellular Microbiology
|January 17, 2007
PubMed

Insights

Adherent-invasive Escherichia coli (AIEC) can induce granuloma formation in vitro, mimicking early stages of Crohn's disease (CD) pathology. This finding sheds light on AIEC

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Adherent-invasive Escherichia coli (AIEC) are strongly linked to ileal Crohn's disease (CD).
  • AIEC survive and replicate within macrophages by exploiting the low pH of the phagolysosome.
  • Granulomas are a hallmark histopathological feature of Crohn's disease.

Purpose of the Study:

  • To investigate if AIEC LF82 induces granuloma formation in an in vitro model.
  • To compare AIEC-induced granulomas to those seen in Crohn's disease.

Main Methods:

  • Utilized an in vitro model of human granulomas using blood-derived mononuclear cells.
  • Infected macrophages with AIEC LF82 and observed cellular responses.
  • Employed light microscopy, scanning electron microscopy, and histological analysis.
  • Tested the effect of soluble protein extracts from AIEC LF82.

Main Results:

  • AIEC LF82 induced macrophage aggregation and fusion into multinucleated giant cells.
  • Lymphocytes were recruited to the developing cell aggregates.
  • Microscopic and histological analyses confirmed granuloma-like features.
  • Soluble protein extracts of AIEC LF82 could also induce these structures.

Conclusions:

  • AIEC LF82 can induce the formation of structures resembling early-stage epithelioid granulomas in vitro.
  • This model provides insights into the pathogenesis of Crohn's disease associated with AIEC.
  • Further research is needed to fully elucidate the mechanisms and relevance to in vivo CD granulomas.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...